Ledger.Open graph →
SEC Form D · filed April 23, 2015

Voyager Therapeutics, Inc

Offering
—
Sold
$60.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

James Geraghty · Cambridge, MADirectorMitchell S. Bloom · Boston, MAExecBrett W. Gerber · Almena, WIExecSteven Paul · Cambridge, MAExec · DirectorMark Levin · Boston, MADirectorBellus Capital, LLC · New York, NYExecSteven Paul · Cambridge, MAExec · DirectorJames Geraghty · Cambridge, MADirectorMark Levin · Rockville, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗